論文 - 新岡 丈典
-
H2-receptor antagonist influences dasatinib pharmacokinetics in a patient with Philadelphia-positive acute lymphoblastic leukemia.
Matsuoka Akihito, Takahashi Naoto, Miura Masatomo, Niioka Takenori, Kawakami Kimihiro, Matsunaga Takuya, Sawada Kenichi
Cancer Chemother Pharmacol 70 ( 2 ) 351 - 352 2012年08月
-
Pharmacokinetics of dasatinib for Philadelphia-positive acute lymphocytic leukemia with acquired T315I mutation.
Takahashi Naoto, Miura Masatomo, Scott Stuart A, Niioka Takenori, Sawada Kenichi
J Hematol Oncol 5 23 - 23 2012年05月
-
Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers.
Saruwatari Junji, Yasui-Furukori Norio, Niioka Takenori, Akamine Yumiko, Takashima Ayaka, Kaneko Sunao, Uno Tsukasa
J Clin Psychopharmacol 32 ( 2 ) 195 - 199 2012年04月
-
Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients.
Takahashi Naoto, Miura Masatomo, Niioka Takenori, Sawada Kenichi
Cancer Chemother Pharmacol 69 ( 4 ) 999 - 1004 2012年04月
-
Influence of NAT2 polymorphisms on sulfamethoxazole pharmacokinetics in renal transplant recipients.
Kagaya Hideaki, Miura Masatomo, Niioka Takenori, Saito Mitsuru, Numakura Kazuyuki, Habuchi Tomonori, Satoh Shigeru
Antimicrob Agents Chemother 56 ( 2 ) 825 - 829 2012年02月
-
Monitoring of mycophenolic acid predose concentrations in the maintenance phase more than one year after renal transplantation.
Miura Masatomo, Niioka Takenori, Kato Shoutaro, Kagaya Hideaki, Saito Mitsuru, Habuchi Tomonori, Satoh Shigeru
Ther Drug Monit 33 ( 3 ) 295 - 302 2011年06月
-
Pharmacogenetic determinants for interindividual difference of tacrolimus pharmacokinetics 1 year after renal transplantation.
Miura M, Niioka T, Kagaya H, Saito M, Hayakari M, Habuchi T, Satoh S
J Clin Pharm Ther 36 ( 2 ) 208 - 216 2011年04月
-
Clinical usefulness of limited sampling strategies for estimating AUC of proton pump inhibitors.
Niioka Takenori
Yakugaku Zasshi 131 ( 3 ) 407 - 413 2011年03月
-
Influence of CYP2C19 and ABCB1 polymorphisms on plasma concentrations of lansoprazole enantiomers after enteral administration.
Miura Masatomo, Motoyama Satoru, Hinai Yudai, Niioka Takenori, Endo Masahiro, Hayakari Makoto, Ogawa Jun-ichi
Xenobiotica 40 ( 9 ) 630 - 636 2010年09月
-
Correlation between R/S enantiomer ratio of lansoprazole and CYP2C19 activity after single oral and enteral administration.
Miura Masatomo, Motoyama Satoru, Hinai Yudai, Niioka Takenori, Hayakari Makoto, Ogawa Jun-ichi, Suzuki Toshio
Chirality 22 ( 7 ) 635 - 640 2010年07月
-
モンテカルロシミュレーションを用いた肺炎球菌感染が疑われる高齢者におけるレボフロキサシン適正用量の検討
岡村 祐嗣, 新岡 丈典, 木村 正彦, 保嶋 実, 早狩 誠
医療薬学 36 ( 8 ) 592 - 598 2010年
-
CYP2C19 genotype-based (R)-warfarin disposition assessment: some views on data analysis.
Niioka Takenori, Uno Tsukasa
J Clin Pharm Ther 34 ( 5 ) 611 - 612 2009年10月
-
Early phase limited sampling strategy characterizing tacrolimus and mycophenolic acid pharmacokinetics adapted to the maintenance phase of renal transplant patients.
Miura Masatomo, Satoh Shigeru, Niioka Takenori, Kagaya Hideaki, Saito Mitsuru, Hayakari Makoto, Habuchi Tomonori, Suzuki Toshio
Ther Drug Monit 31 ( 4 ) 467 - 474 2009年08月
-
Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations.
Fujii Akira, Yasui-Furukori Norio, Nakagami Taku, Niioka Takenori, Saito Manabu, Sato Yasushi, Kaneko Sunao
Drug Des Devel Ther 2 139 - 144 2009年02月
-
Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers.
Niioka Takenori, Miura Masatomo, Uno Tsukasa, Yasui-Furukori Norio, Hayakari Makoto, Tateishi Tomonori, Suzuki Toshio
Eur J Clin Pharmacol 64 ( 5 ) 503 - 509 2008年05月
-
Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients.
Miura Masatomo, Satoh Shigeru, Niioka Takenori, Kagaya Hideaki, Saito Mitsuru, Hayakari Makoto, Habuchi Tomonori, Suzuki Toshio
Ther Drug Monit 30 ( 1 ) 52 - 59 2008年02月
-
Estimation of CYP2C19 activity by the omeprazole hydroxylation index at a single point in time after intravenous and oral administration.
Niioka Takenori, Uno Tsukasa, Sugimoto Katsuyoshi, Sugawara Kazunobu, Hayakari Makoto, Tateishi Tomonori
Eur J Clin Pharmacol 63 ( 11 ) 1031 - 1038 2007年11月
-
Simultaneous determination of warfarin enantiomers and its metabolite in human plasma by column-switching high-performance liquid chromatography with chiral separation.
Uno Tsukasa, Niioka Takenori, Hayakari Makoto, Sugawara Kazunobu, Tateishi Tomonori
Ther Drug Monit 29 ( 3 ) 333 - 339 2007年06月
-
Different serum concentrations of steady-state valproic acid in two sustained-release formulations.
Yasui-Furukori Norio, Saito Manabu, Nakagami Taku, Niioka Takenori, Sato Yasushi, Fujii Akira, Kaneko Sunao
Psychiatry Clin Neurosci 61 ( 3 ) 308 - 312 2007年06月
-
Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
Niioka Takenori, Uno Tsukasa, Yasui-Furukori Norio, Takahata Takenori, Shimizu Mikiko, Sugawara Kazunobu, Tateishi Tomonori
Cancer Chemother Pharmacol 59 ( 5 ) 575 - 580 2007年04月